Xiaoli Zhang, PhD, is currently an Associate Professor on the Clinical Track in the Department of Biomedical Informatics and Center for Biostatistics. Her research focuses on biomarker discoveries/selections and predictive modeling using statistical and bioinformatics method based on genomics, proteomics, and metabolomics data, particularly in cancer stemness, cancer immunology, and cancer metabolic reprogramming that leads to tumor metastasis and drug resistance. Besides her research, Dr. Zhang has over 16 years of extensive experience in collaborative research as a team scientist. She is actively involved in collaborative work on a broad range of biomedical research areas, mainly in the field of cancer research, microbial infection, and immunity. Because of her overarching achievements in obtaining extramural funding and publishing in high impact journals, she was recognized by the department as the awardee of the inaugural BMI “Award for Excellence in Collaborative Research” in 2020.
Prior to her faculty position, Dr. Zhang was a Research Scientist in the Center for Biostatistics from 2006 to 2018. She earned her PhD in molecular, cellular, and developmental biology (minor in genetics) and a MS in Statistics from Iowa State University in 2006.
Education and Training
MS, Statistics, Iowa State University, 2007
PhD, Molecular, Cellular, and Developmental Biology, Iowa State University, 2006
MS, Cellular and Molecular Biology, University of Science and Technology of China, 2001
BS, Biochemistry, Yantai University, China, 1995
Areas of Expertise
- Gene expression experimental design (mRNAs, miRNAs, and proteins), high dimensional data reduction, data analysis, and ingenuity pathway analysis (IPA)
- Bioassay experiment design and data analysis
- Regression modeling including linear, Cox proportional hazard, mixed-effects, and logistic regression
- Basic science laboratory experimental design and data analysis
- Survival data modeling
Center for Biostatistics
320B Lincoln Tower, 1800 Cannon Drive
Columbus, OH 43210